Siddharth P. Shah, MD
Renal Electrolyte and Hypertension
Headshot of Siddharth P. Shah, MD

Siddharth P. Shah, MD

Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension Perelman
View 1 additional location
Headshot of Siddharth P. Shah, MD
Penn Medicine Provider

About me

  • Director, Kidney Stone Evaluation Center
  • Medical Director, 42nd & Walnut Dialysis Center
  • Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Temple University School of MedicineMedical School
  • Northwestern Memorial HospitalResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English

Reviews

Average Rating

684 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
He's thorough and efficient. I have already several friends to him
Anonymous
September 2026
He is great
Anonymous
September 2026
No matter how busy his schedule is, Dr Shah always always takes the time to review all lab results, all test results, compares them to past results with a full explanation! He explains expectations, steers me in the right direction to maintain my health ongoing. I love that he allows family member to enter the room and ask questions. He is always kind, courteous, and professional! I would highly recommend him to any of my family and or friends!
Anonymous
September 2026
He has shown me how to reduce my likelihood of having reoccurring kidney stones

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Shah is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Opare-Addo K, Spiardi R, Ocampo-Mascaro J, Shah S A Red Herring? SLC34A3 Variant of Uncertain Significance in a Woman with Fractures and Kidney Stones , Annual Meeting of the American Society of Nephrology: 2026


Potluri V, Sawinski D, Tam V, Shults J, Cohen J, Wiebe D, Shah S, Berns J, Reese P. Effect of Neighborhood Food Environment and Socioeconomic Status on Serum Phosphorus Level for Patients on Chronic Dialysis , Journal of the American Society of Nephrology, 31(11): 2020,2622-2630


Wong T, Lejbman J, Snider C, Porges S, Shah S. A Quality Improvement Program to Reduce Avoidable Hospital Stays for Dialysis Patients Presenting to the Emergency Department. , Annual Meeting of the American Society of Nephrology: 2019


Joshi S, Potluri V, Shah S. Dietary Management of Hyperphosphatemia. In reply to: Phosphate-binder use in US dialysis patients: prevalence, cost, evidence, and policies. , Am J Kidney Dis., 71: 2018,246-253


Suarez J, Cohen J, Potluri V, Yang W, Kaplan D, Serper M, Shah S, Reese P. Racial Disparities in Nephrology Consultation and Disease Progression among Veterans with CKD: An Observational Cohort Study. , J Am Soc Nephrol., 29: 2018,1-11


Shah S, Acholonu RG, Ohene-Frempong K, Asakura T Filterability of freshly-collected sickle erythrocytes under venous oxygen pressure without exposure to air , Blood Cells, Molecules and Diseases, 55(4): 2015,328-335


Shah S, Glickman J Disorders of Water Homeostasis: Hyponatremia and Hypernatremia , The Intensive Care Unit Manual, Chapter 84, 2nd Edition: 2014,792-802


Wu SW, Shah S, Sterling KA, Rudnick MR Prevention of Contrast-Induced Nephropathy , US Nephrology, 4: 2009,35-38


Lam A, Shah S, Paparello J Outpatient Management of Chronic Kidney Disease: proteinuria, anemia and bone disease as therapeutic targets , Am J Therapeutics, 15: 2008,278-286


Friedewald J, Shah SP, Desai U, Hively-Johnson S, Gheorghiade M, Kaufman D Prevalence of CAD in patients with diabetes mellitus type 1 being evaluated for pancreas or kidney and pancreas transplant. , Annual Meeting of the World Transplant Congress: 2006